Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells

17 May 2024

Abstract excerpt

Despite considerable therapeutic advancements, the global survival rate for lung cancer patients remains poor, posing challenges in developing an effective treatment strategy. In many cases, microRNAs (miRNAs) exhibit abnormal expression levels in cancers, including lung cancer. Dysregulated miRNAs often play a crucial role in the development and progression of cancer. Therefore, understanding the mechanisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38763409
DOI: 10.1016/j.bbadis.2024.167250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cellsPMID 38763409Read ↗

Cell Cycle Protein Cyclin Y Is Associated With Human Non–Small-Cell Lung Cancer Proliferation and TumorigenesisSemantic proximity Read ↗

Expression of CDCA7 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-small Cell Lung Cancer Semantic proximity Read ↗

NCAPG 2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinomaSemantic proximity Read ↗

Highly expressed long non‐coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non‐small cell lung carcinomaSemantic proximity Read ↗

MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancerSemantic proximity Read ↗

Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2Semantic proximity Read ↗

RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growthSemantic proximity Read ↗

CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1Semantic proximity Read ↗

MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLCSemantic proximity Read ↗

Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.Semantic proximity Read ↗

MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8Semantic proximity Read ↗

MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.